Current trends in the management of homozygous β-thalassemia

Annals of Saudi Medicine

Volumn 16, Issue 5, 1996, Pages 554-558

  Pearson, Howard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT;

BETA THALASSEMIA; BLOOD TRANSFUSION; HOMOZYGOSITY; PRIORITY JOURNAL; SHORT SURVEY; SPLENECTOMY;

EID: 0029862268     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1996.554     Document Type: Short Survey

References (29)

1. Silvestroni E, Bianco I. Screening for microcytosis in Italy. Am J Hum Gen 1975;27:198.
2. Pearson HA. Thalassemia intermedia, Ann NY Acad Sci 1964;119:390.
3. Caffey J. Cooley's anemia: a review of the roentgenographic findings. Am J Rad 1957;78:381.
4. Pearson HA. Clinical aspects of the β-thalassemias. In: Handin RI, Lux SE, Stossel TP, editors. Blood, Principles and Practice of Hematology. Philadelphia: Lippincott, 1995:1566.
5. Kruatrachue M, Sirisinha S, Pacharee P, et al. An association between thalassemia and autoimmune hemolytic anemia. Scand J Haematol 1980;25:259.
6. Piomelli S, Karpatkin M, Arzanian M, et al. Hypertransfusion regimen in patients with Cooley's anemia. Ann NY Acad Sci 1974;232:186.
7. Propper RD, Button LN, Nathan DG. New approaches to the transfusion management of thalassemia. Blood 1980;55:55.
8. Corash L, Klein H, Deisseroth A, et al. Selective isolation of young erythrocytes for transfusion support of thalassemia major patients. Blood 1981;57:599.
9. Cohen AR, Schmidt JM, Martin MB, et al. Clinical trial of young red cell transfusions. J Pediatr 1984;104:865.
10. Smith CH, Erlandson ME, Stern G, et al. Postsplenectomy infection in Cooley's anemia. N Engl J Med 1962;266:737.
11. Singer DB. Postsplenectomy sepsis. Perspect Ped Path 1973 ;1:285.
12. Falletta J, Wools GM, Veiter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. J Pediatr 1995;127:685.
13. Roche G, Leheup B, Gerard A, et al. Septicemia: a Yersinia enterolitica - revue generale. Rev Med Intern 1982;3:65.
14. Katz BZ. Vibrio vulnificus meningitis in a boy with thalassemia after eating raw oysters. Pediatrics 1988;82:784.
15. Propper ED, Cooper B, Ruffo RR, et al. Continuous subcutaneous administration of desferrioxamine in patients with iron overload. N Engl J Med 1977;297:418.
16. Smith RS. Iron excretion in thalassemia major after administration of chelating agents. Br Med J 1962;1:1577.
17. Olivieri NF, Koren G, Matsui D, et al. Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia. Blood 1992;79:2741.
18. Giardina PJ, Grady RW, Ehlers JM, et al. Chelation therapy in Cooley's anemia: a decade of experience with subcutaneous desferrioxamine in thalassemia major. Ann NY Acad Sci 1990;612:275.
19. Olivieri NG, Nathan DG, MacMillan JH, et al. Survival of medically treated patients with homozygous β-thalassemia. N Engl J Med 1994;331:574.
20. Pearson HA, Cohen AR, Giardina PJ, et al. Survival and demography in thalassemia major. Pediatrics 1996.
21. Alter BP. Antenatal diagnosis of thalassemia. Ann NY Acad Sci 1985;445:393.
22. Cao A, Rossatelli C, Gallenello R, et al. The prevention of homozygous beta thalassemia by carrier screening and prenatal diagnosis in Sardinia. Clin Genet 1989;36:277-85.
23. Pearson HA, Guiliotis DK, Rink L, et al. Patient age distribution in thalassemia major: changes between 1973 and 1985. Pediatrics 1987;80:53.
24. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in thalassemia. N Engl J Med 1990;322:417.
25. Walters MC, Thomas ED. Bone marrow transplantation for thalassemia. The USA experience. Am J Ped Hem One 1994;16:11.
26. Stamatoyannopoulos GA, Nienhuis AW. Therapeutic approaches to hemoglobin switching in treatment of the hemoglobinopathies. Ann Rev Med 1992;43:497.
27. Perrine SP, Gonder GD, Little J, et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β globin disorders. N Engl J Med 1993;338:81.
28. Sher GD, Gonder GD, Little J, et al. Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. N Engl J Med 1995;332:1606.
29. Dover DJ, Brusolow SW, Samid DV. Increased fetal hemoglobin in patients receiving sodium 4 phenylbutyrate. N Engl J Med 1995:337.